Table 3: Open in new tab The correlation...

Variables	AVVR < moderate	AVVR ≥ moderate
Total period
Dysfunction < moderate	3333	1620	1713	607	421	186
Dysfunction ≥ moderate	227	127	100	165	103	62
% incidence of dysfunction ≥ moderate	6.4	7.3	5.5	21.4**	19.7**	25.0**
Post-Norwood (0–30)
Dysfunction < moderate	1005	545	460	150	120	30
Dysfunction ≥ moderate	109	49	60	50	23	27
%incidence of dysfunction ≥ moderate	9.8	8.2	11.5	25.0**	16.1**	47.4**
Post-Norwood (31–90)
Dysfunction < moderate	402	200	202	110	87	23
Dysfunction ≥ moderate	14	14	0	12	12	0
%incidence of dysfunction ≥ moderate	3.4	6.5	0.0	9.8**	12.1	0.0
Post-Norwood (91-BCPS)
Dysfunction < moderate	269	114	155	66	40	26
Dysfunction ≥ moderate	12	10	2	3	3	0
%incidence of dysfunction ≥ moderate	4.3	8.1	1.3	4.3	7.0	0.0
Post-BCPS (0–30)
Dysfunction < moderate	602	349	253	108	82	26
Dysfunction ≥ moderate	39	30	9	38	34	4
% incidence of dysfunction ≥ moderate	6.1	7.9	3.4	26.0**	29.3**	13.3*
Post-BCPS (31–90)
Dysfunction < moderate	210	98	112	34	21	13
Dysfunction ≥ moderate	19	10	9	20	13	7
%incidence of dysfunction ≥ moderate	8.3	9.3	7.4	37.0**	38.2**	35.0**
Post-BCPS (91-TCPC)
Dysfunction < moderate	844	313	531	139	71	68
Dysfunction ≥ moderate	33	14	19	42	18	24
%incidence of dysfunction ≥ moderate	3.8	4.3	3.5	23.2**	20.2**	26.1**

Variables

AVVR < moderate

AVVR ≥ moderate

Total

MBTS

RVPAC

Total

MBTS

RVPAC

Total period

Dysfunction < moderate

3333

1620

1713

607

421

186

Dysfunction ≥ moderate

227

127

100

165

103

% incidence of dysfunction ≥ moderate

6.4

7.3

5.5

21.4**

19.7**

25.0**

Post-Norwood (0–30)

Dysfunction < moderate

1005

545

460

150

120

Dysfunction ≥ moderate

109

%incidence of dysfunction ≥ moderate

9.8

8.2

11.5

25.0**

16.1**

47.4**

Post-Norwood (31–90)

Dysfunction < moderate

402

200

202

110

Dysfunction ≥ moderate

%incidence of dysfunction ≥ moderate

3.4

6.5

0.0

9.8**

12.1

0.0

Post-Norwood (91-BCPS)

Dysfunction < moderate

269

114

155

Dysfunction ≥ moderate

%incidence of dysfunction ≥ moderate

4.3

8.1

1.3

4.3

7.0

0.0

Post-BCPS (0–30)

Dysfunction < moderate

602

349

253

108

Dysfunction ≥ moderate

% incidence of dysfunction ≥ moderate

6.1

7.9

3.4

26.0**

29.3**

13.3*

Post-BCPS (31–90)

Dysfunction < moderate

210

112

Dysfunction ≥ moderate

%incidence of dysfunction ≥ moderate

8.3

9.3

7.4

37.0**

38.2**

35.0**

Post-BCPS (91-TCPC)

Dysfunction < moderate

844

313

531

139

Dysfunction ≥ moderate

%incidence of dysfunction ≥ moderate

3.8

4.3

3.5

23.2**

20.2**

26.1**

Variables	AVVR < moderate	AVVR ≥ moderate
Total period
Dysfunction < moderate	3333	1620	1713	607	421	186
Dysfunction ≥ moderate	227	127	100	165	103	62
% incidence of dysfunction ≥ moderate	6.4	7.3	5.5	21.4**	19.7**	25.0**
Post-Norwood (0–30)
Dysfunction < moderate	1005	545	460	150	120	30
Dysfunction ≥ moderate	109	49	60	50	23	27
%incidence of dysfunction ≥ moderate	9.8	8.2	11.5	25.0**	16.1**	47.4**
Post-Norwood (31–90)
Dysfunction < moderate	402	200	202	110	87	23
Dysfunction ≥ moderate	14	14	0	12	12	0
%incidence of dysfunction ≥ moderate	3.4	6.5	0.0	9.8**	12.1	0.0
Post-Norwood (91-BCPS)
Dysfunction < moderate	269	114	155	66	40	26
Dysfunction ≥ moderate	12	10	2	3	3	0
%incidence of dysfunction ≥ moderate	4.3	8.1	1.3	4.3	7.0	0.0
Post-BCPS (0–30)
Dysfunction < moderate	602	349	253	108	82	26
Dysfunction ≥ moderate	39	30	9	38	34	4
% incidence of dysfunction ≥ moderate	6.1	7.9	3.4	26.0**	29.3**	13.3*
Post-BCPS (31–90)
Dysfunction < moderate	210	98	112	34	21	13
Dysfunction ≥ moderate	19	10	9	20	13	7
%incidence of dysfunction ≥ moderate	8.3	9.3	7.4	37.0**	38.2**	35.0**
Post-BCPS (91-TCPC)
Dysfunction < moderate	844	313	531	139	71	68
Dysfunction ≥ moderate	33	14	19	42	18	24
%incidence of dysfunction ≥ moderate	3.8	4.3	3.5	23.2**	20.2**	26.1**

Table 3:

Open in new tab

The correlation between AVVR and ventricular dysfunction

Variables	AVVR < moderate			AVVR ≥ moderate
	Total	MBTS	RVPAC	Total	MBTS	RVPAC
Total period
Dysfunction < moderate	3333	1620	1713	607	421	186
Dysfunction ≥ moderate	227	127	100	165	103	62
% incidence of dysfunction ≥ moderate	6.4	7.3	5.5	21.4**	19.7**	25.0**
Post-Norwood (0–30)
Dysfunction < moderate	1005	545	460	150	120	30
Dysfunction ≥ moderate	109	49	60	50	23	27
%incidence of dysfunction ≥ moderate	9.8	8.2	11.5	25.0**	16.1**	47.4**
Post-Norwood (31–90)
Dysfunction < moderate	402	200	202	110	87	23
Dysfunction ≥ moderate	14	14	0	12	12	0
%incidence of dysfunction ≥ moderate	3.4	6.5	0.0	9.8**	12.1	0.0
Post-Norwood (91-BCPS)
Dysfunction < moderate	269	114	155	66	40	26
Dysfunction ≥ moderate	12	10	2	3	3	0
%incidence of dysfunction ≥ moderate	4.3	8.1	1.3	4.3	7.0	0.0
Post-BCPS (0–30)
Dysfunction < moderate	602	349	253	108	82	26
Dysfunction ≥ moderate	39	30	9	38	34	4
% incidence of dysfunction ≥ moderate	6.1	7.9	3.4	26.0**	29.3**	13.3*
Post-BCPS (31–90)
Dysfunction < moderate	210	98	112	34	21	13
Dysfunction ≥ moderate	19	10	9	20	13	7
%incidence of dysfunction ≥ moderate	8.3	9.3	7.4	37.0**	38.2**	35.0**
Post-BCPS (91-TCPC)
Dysfunction < moderate	844	313	531	139	71	68
Dysfunction ≥ moderate	33	14	19	42	18	24
%incidence of dysfunction ≥ moderate	3.8	4.3	3.5	23.2**	20.2**	26.1**

Variables	AVVR < moderate			AVVR ≥ moderate
	Total	MBTS	RVPAC	Total	MBTS	RVPAC
Total period
Dysfunction < moderate	3333	1620	1713	607	421	186
Dysfunction ≥ moderate	227	127	100	165	103	62
% incidence of dysfunction ≥ moderate	6.4	7.3	5.5	21.4**	19.7**	25.0**
Post-Norwood (0–30)
Dysfunction < moderate	1005	545	460	150	120	30
Dysfunction ≥ moderate	109	49	60	50	23	27
%incidence of dysfunction ≥ moderate	9.8	8.2	11.5	25.0**	16.1**	47.4**
Post-Norwood (31–90)
Dysfunction < moderate	402	200	202	110	87	23
Dysfunction ≥ moderate	14	14	0	12	12	0
%incidence of dysfunction ≥ moderate	3.4	6.5	0.0	9.8**	12.1	0.0
Post-Norwood (91-BCPS)
Dysfunction < moderate	269	114	155	66	40	26
Dysfunction ≥ moderate	12	10	2	3	3	0
%incidence of dysfunction ≥ moderate	4.3	8.1	1.3	4.3	7.0	0.0
Post-BCPS (0–30)
Dysfunction < moderate	602	349	253	108	82	26
Dysfunction ≥ moderate	39	30	9	38	34	4
% incidence of dysfunction ≥ moderate	6.1	7.9	3.4	26.0**	29.3**	13.3*
Post-BCPS (31–90)
Dysfunction < moderate	210	98	112	34	21	13
Dysfunction ≥ moderate	19	10	9	20	13	7
%incidence of dysfunction ≥ moderate	8.3	9.3	7.4	37.0**	38.2**	35.0**
Post-BCPS (91-TCPC)
Dysfunction < moderate	844	313	531	139	71	68
Dysfunction ≥ moderate	33	14	19	42	18	24
%incidence of dysfunction ≥ moderate	3.8	4.3	3.5	23.2**	20.2**	26.1**

P < 0.05.

P < 0.01.

AVVR: atrioventricular valve regurgitation; BCPS: bidirectional cavopulmonary shunt; MBTS: modified Blalock–Taussig shunt; RVPAC: right ventricle to pulmonary artery conduit; TCPC: total cavopulmonary connection.

This Feature Is Available To Subscribers Only